LLY.CI

Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs · BCBA:LLY.CI

41,520.00 ARS1,200.00 +2.98%

Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs (BCBA:LLY.CI) last traded at 41,520.00 ARS, up 2.98% on the day. Over the past year the stock is up 89.16%. Its 52-week range is 22,780.00 to 42,440.00. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open41,480.00

Day range40,620.00 – 42,440.00

52-week range22,780.00 – 42,440.00

Volume2.15 K

Average volume (10 days)1.44 K

Market cap (USD)1.33 T

P/E53.09

EPS (TTM) (USD)0.5123

Dividend yield0.27%

Beta (1 year)−0.006840

Revenue (TTM) (USD)81.72 B

Employees50.00 K

Performance

+9.61%1 week

+21.90%1 month

+30.48%3 months

+74.60%6 months

+40.27%Year to date

+89.16%1 year

Technical rating

Strong buy

Daily summary of 11 oscillators and 15 moving averages. See every indicator

Latest headlines

Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
Healthcare sector rallies in October amid rotation away from technology stocksSeeking Alpha · 31 Oct 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Elon Musk Says Eli Lilly Has ‘Some Banger Drugs Coming Out’ After CEO Dave Ricks Bets Against Vinod Khosla's Big Biotech SkepticismBenzinga · 31 Oct 2026
Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3Stocktwits · 31 Oct 2026
Eli Lilly Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
UBS maintains Eli Lilly at Buy, raises price target to $1625 from $1425TradingView · 31 Oct 2026
What Eli Lilly and Company (LLY) Said on Its Q3 Earnings CallMarketBeat · 30 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.